SIGHTS SET ON INNOVATION: New Approaches to Vision with Microchips Holds out Prospects for the Blind
To date, chip-based retinal implants have only permitted a rudimentary restoration of vision. However, modifying the electrical signals emitted by the implants could change that.
This is the conclusion of the initial published findings of a project sponsored by the Austrian Science Fund FWF, which showed that two specific retinal cell types respond differently to certain electrical signals – an effect that could improve the perception of light-dark contrasts.
"Making the blind really see – that will take some time", says Frank Rattay of the Institute of Analysis and Scientific Computing at the Vienna University of Technology – TU Wien. "But in the case of certain diseases of the eyes, it is already possible to restore vision, albeit still highly impaired, by means of retinal implants."
To achieve this, microchips implanted in the eye convert light signals into electrical pulses, which then stimulate the cells of the retina. One major problem with this approach is that the various types of cells that respond differently to light stimuli in a healthy eye are all stimulated to the same degree. This greatly reduces the perception of contrast.
"But it might be possible", Rattay says, "to stimulate one cell type more than the other by means of special electrical pulses, thus enhancing the perception of contrast."
Within the framework of an FWF project, he and his team have discovered some promising approaches. Together with colleagues Shelley Fried of Harvard Medical School and Eberhard Zrenner of University Hospital Tübingen, he is now corroborating the simulated results with experimental findings.
SIMULATED & STIMULATED
With the help of a sophisticated computer simulation of two retinal cell types, Rattay and his team have discovered something very exciting. They found that by selecting specific electrical pulses, different biophysical processes can actually be activated in the two cell types. For example, monophasic stimulation, where the electrical polarity of the signal from the retinal implant does not change, leads to stronger depolarisation in one cell type than in the other.
"Depolarisation means that the negative charge that prevails in cells switches briefly to a positive charge. This is the mechanism by which signals are propagated along nerves", Rattay explains. This charge reversal was significantly weaker in the other cell type. In their simulation, the team also found as much as a fourfold difference in the response of calcium concentrations in the two cell types to a monophasic signal.
ON AND OFF
"Calcium is an important signal molecule in many cells and plays a key role in information processing. For this reason, we specifically considered calcium concentrations in our simulation by considering the activity of membrane proteins involved in calcium transport", explains Paul Werginz, a colleague of Rattay and lead author of the recently published paper. Concretely, the team devised models of two retinal cell types that are designated as ON and OFF cells.
ON cells react more strongly when the light is brighter at the centre of their location, while OFF cells react more strongly when the light is more intense at the edges. The two cell types are arranged in the retina in such a way as to greatly enhance contrast. The problem is that instead of light pulses, conventional retinal implants emit electrical pulses that elicit the same biochemical reactions in both cell types. Consequently, contrast perception is greatly reduced. However, Rattay's work shows that this needn't be the case.
SHAPE AS A FACTOR
Rattay's research group also found that the shape of the individual ON and OFF cells affect the way in which the signals are processed. For example, the different length of the two cell types is an important factor. This too, Rattay believes, could be an important finding that might help to significantly improve the performance of future retinal implants by modulating the electrical signals they emit. Rattay and his team are in hot pursuit of this goal in order to develop strategies that will allow many blind people to recognise objects visually.
Frank Rattay is a professor at the Institute of Analysis and Scientific Computing of the Vienna University of Technology, where he heads the Computational Neuroscience and Biomedical Engineering group. For decades he has been publishing internationally recognised work on the generation and optimisation of artificial nerve signals.
Original publication: Modeling the response of ON and OFF retinal bipolar cells during electric stimulation. Vision Research Dec. 2014. P. Werginz, H. Benav, E. Zrenner, F. Rattay. DOI: dx.doi.org/10.1016/j.visres.2014.12.002
Video showing the stimulation of nerve cells in the retina: https://www.youtube.com/watch?v=wQyURbqOTYg
Image and text available from Monday, 11 May 2015, from 10.00 am CEST at:
Prof. Frank Rattay
Vienna University of Technology Institute of Analysis and Scientific Computing Wiedner Hauptstr. 8–10
1040 Vienna, Austria
T +43 / 1 / 58 801 - 10114
Austrian Science Fund FWF:
Haus der Forschung
1090 Vienna, Austria
T +43 / 1 / 505 67 40 - 8111
Copy Editing & Distribution:
PR&D – Public Relations for Research & Education Mariannengasse 8
1090 Vienna, Austria
T +43 / 1 / 505 70 44
Marc Seumenicht | PR&D – Public Relations for Research & Education
Virtual Reality in Medicine: New Opportunities for Diagnostics and Surgical Planning
07.12.2016 | Universität Basel
3-D printed kidney phantoms aid nuclear medicine dosing calibration
06.12.2016 | Society of Nuclear Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine